HepaTx is a regenerative medicine biotechnology company developing off-the-shelf, allogeneic stem cell-based therapies for late-stage and chronic liver disease
HepaTx is a regenerative medicine biotechnology company developing off-the-shelf, allogeneic stem cell-based therapies for late-stage and chronic liver disease. Its process differentiates adipose tissue-derived stromal cells into functional hepatocyte-like cells, which are infused into the liver to support regeneration and restore liver function as an alternative to transplantation.